The appearance and increasing prevalence of methicillin-resistant and multidrug-resistant staphylococcal skin infections has necessitated a change in how those infections are treated. Topical antibacterial treatments have evolved from elective adjunctive therapy to a more essential part of the treatment plan. This article reviews the ingredients and vehicles available for aggressive topical antibacterial treatment and prevention of Staphylococcus skin infections. Additionally, the basic tenets of improving client compliance and product efficacy are outlined.